Literature DB >> 21407518

Effects of Early Serum Treatment on Pneumococcus Type I Pneumonia.

R L Cecil.   

Abstract

Year:  1936        PMID： 21407518      PMCID： PMC2242125     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  1 in total

1.  THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA III. INJECTED IMMUNE SUBSTANCES (ANTIPNEUMOCOCCUS SERUM, TYPES I AND II).

Authors:  O H Robertson; J B Graeser; L T Coggeshall; R H Sia
Journal:  J Clin Invest       Date:  1934-07       Impact factor: 14.808
  1 in total
  2 in total

1.  SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.

Authors:  Arturo Casadevall; Michael J Joyner; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

2.  Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres.

Authors:  Jens Gottlieb; Martin Kolditz; Nils Gade; Tobias Welte; Nikolaus Kneidinger
Journal:  Eur Respir J       Date:  2022-07-21       Impact factor: 33.795
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.